Non small cell lung cancer epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
(→Gender) |
Ahmed Younes (talk | contribs) |
||
| (6 intermediate revisions by one other user not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Non-small cell lung cancer is the most common cancer worldwide and the leading cause of [[Mortality|cancer-related mortality]] in the United States. Non small cell lung cancer accounted for 1.8 million new cases and 1.6 million deaths of lung cancer in 2012. In the United States, the age-adjusted [[prevalence]] of non small cell lung cancer is 47.2 per 100,000 | Non-small cell lung cancer is the most common cancer worldwide and the leading cause of [[Mortality|cancer-related mortality]] in the United States. Non-small cell lung cancer accounted for 1.8 million new cases and 1.6 million deaths of lung cancer in 2012. In the United States, the age-adjusted [[prevalence]] of non-small cell lung cancer is 47.2 per 100,000 individuals. The median age at diagnosis of non-small cell lung cancer is 70 years. Non-small cell lung cancer is most frequently diagnosed among people between 65 to 74 years old. Males are more commonly affected by non-small cell lung cancer than females. The male to female ratio is approximately 1.8 to 1. The rate of new cases in 2011 showed that males develop lung cancer more often than females (64.8 and 48.6 per 100,000 individuals). There is a racial preponderance to the development of non-small cell lung cancer, where African American individuals are at a significantly increased risk compared to Caucasian race. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
* In the United States, the age-adjusted [[prevalence]] of non small cell lung cancer is 47.2 per 100,000 indivudals.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/statfacts/html/lungb.html, based on November 2013 SEER data submission, posted to the SEER web site. February 2016.</ref> | * In the United States, the age-adjusted [[prevalence]] of non-small cell lung cancer is 47.2 per 100,000 indivudals.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/statfacts/html/lungb.html, based on November 2013 SEER data submission, posted to the SEER web site. February 2016.</ref> | ||
* About 85%–90% of all lung cancers are non small cell lung cancer.<ref>Non small cell lung cancer. Canadian cancer society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/lung/lung-cancer/non-small-cell-lung-cancer/?region=ab </ref> | * About 85%–90% of all lung cancers are non-small cell lung cancer.<ref>Non small cell lung cancer. Canadian cancer society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/lung/lung-cancer/non-small-cell-lung-cancer/?region=ab </ref> | ||
* The most common type of lung cancer is non small cell lung cancer.<ref name="pmid18452692">{{cite journal |vauthors=Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA |title=Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship |journal=Mayo Clin. Proc. |volume=83 |issue=5 |pages=584–94 |year=2008 |pmid=18452692 |pmc=2718421 |doi=10.4065/83.5.584 |url=}}</ref><ref name="lung">Tumors of the lung: epidemiology. WHO/IARC. 2006 https://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/bb10-chap1.pdf Accessed on February 21, 2016</ref> | * The most common type of lung cancer is non-small cell lung cancer.<ref name="pmid18452692">{{cite journal |vauthors=Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA |title=Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship |journal=Mayo Clin. Proc. |volume=83 |issue=5 |pages=584–94 |year=2008 |pmid=18452692 |pmc=2718421 |doi=10.4065/83.5.584 |url=}}</ref><ref name="lung">Tumors of the lung: epidemiology. WHO/IARC. 2006 https://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/bb10-chap1.pdf Accessed on February 21, 2016</ref> | ||
**Non small cell lung cancer is the most common cancer worldwide, accounting for 1.8 million new cases and 1.6 million deaths in 2012. | ** Non-small cell lung cancer is the most common cancer worldwide, accounting for 1.8 million new cases and 1.6 million deaths in 2012. | ||
**Adenocarcinoma of the lung is the most common non small cell lung cancer subtype in the United States. | **Adenocarcinoma of the lung is the most common non-small cell lung cancer subtype in the United States. | ||
===Incidence=== | ===Incidence=== | ||
* The age-adjusted [[incidence]] of non small cell lung cancer in 2012 was estimated to be 58.7 per 100,000 individuals in the United States.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 2008-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref> | * The age-adjusted [[incidence]] of non-small cell lung cancer in 2012 was estimated to be 58.7 per 100,000 individuals in the United States.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 2008-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref> | ||
** The incidence rate of [[Adenocarcinoma of the lung|lung adenocarcinoma]] is 22.1 per 100,000 individuals a year. | ** The incidence rate of [[Adenocarcinoma of the lung|lung adenocarcinoma]] is 22.1 per 100,000 individuals a year. | ||
** The incidence rate of [[Squamous-cell carcinoma|lung squamous-cell carcinoma]] is 14.4 per 100,000 individuals a year. | ** The incidence rate of [[Squamous-cell carcinoma|lung squamous-cell carcinoma]] is 14.4 per 100,000 individuals a year. | ||
| Line 22: | Line 22: | ||
===Age=== | ===Age=== | ||
* The incidence of non small cell lung cancer increases with age; the [[median]] age at diagnosis is 70 years.<ref name="pmid19934774">{{cite journal |vauthors=Subramanian J, Morgensztern D, Goodgame B, Baggstrom MQ, Gao F, Piccirillo J, Govindan R |title=Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis |journal=J Thorac Oncol |volume=5 |issue=1 |pages=23–8 |year=2010 |pmid=19934774 |doi=10.1097/JTO.0b013e3181c41e8d |url=}}</ref> | * The incidence of non small cell lung cancer increases with age; the [[median]] age at diagnosis is 70 years.<ref name="pmid19934774">{{cite journal |vauthors=Subramanian J, Morgensztern D, Goodgame B, Baggstrom MQ, Gao F, Piccirillo J, Govindan R |title=Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis |journal=J Thorac Oncol |volume=5 |issue=1 |pages=23–8 |year=2010 |pmid=19934774 |doi=10.1097/JTO.0b013e3181c41e8d |url=}}</ref> | ||
** Non small cell lung cancer is most frequently diagnosed among people among 65 to 74 years old | ** Non small cell lung cancer is most frequently diagnosed among people among 65 to 74 years old. | ||
** Shown below is an image that demonstrates the age-adjusted [[incidence]] of non small cell lung cancer in the United States. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. | ** Shown below is an image that demonstrates the age-adjusted [[incidence]] of non-small cell lung cancer in the United States. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. | ||
===Gender=== | ===Gender=== | ||
* Males are more commonly affected with non small cell lung cancer than females. The male to female ratio is approximately 1.8 to 1.<ref name="pmid19934774">{{cite journal |vauthors=Subramanian J, Morgensztern D, Goodgame B, Baggstrom MQ, Gao F, Piccirillo J, Govindan R |title=Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis |journal=J Thorac Oncol |volume=5 |issue=1 |pages=23–8 |year=2010 |pmid=19934774 |doi=10.1097/JTO.0b013e3181c41e8d |url=}}</ref> | * Males are more commonly affected with non-small cell lung cancer than females. The male to female ratio is approximately 1.8 to 1.<ref name="pmid19934774">{{cite journal |vauthors=Subramanian J, Morgensztern D, Goodgame B, Baggstrom MQ, Gao F, Piccirillo J, Govindan R |title=Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis |journal=J Thorac Oncol |volume=5 |issue=1 |pages=23–8 |year=2010 |pmid=19934774 |doi=10.1097/JTO.0b013e3181c41e8d |url=}}</ref> | ||
* The rate of new cases in 2011 showed that males develop lung cancer more often than females (64.8 and 48.6 per 100,000 individuals). | ** The rate of new cases in 2011 showed that males develop lung cancer more often than females (64.8 and 48.6 per 100,000 individuals). | ||
* Shown below is an image that demonstrates the relative proportions of common types of non small cell lung cancer in the United States, by histology and gender. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. | ** Shown below is an image that demonstrates the relative proportions of common types of non-small cell lung cancer in the United States, by histology and gender. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. | ||
===Race=== | ===Race=== | ||
*There is a racial preponderance to the development of non small cell lung cancer, where African American individuals are at a significantly increased risk compared to Caucasian race<ref name="lung">Tumors of the lung: epidemiology. WHO/IARC. 2006 https://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/bb10-chap1.pdf Accessed on February 21, 2016</ref> | *There is a racial preponderance to the development of non small cell lung cancer, where African American individuals are at a significantly increased risk compared to Caucasian race.<ref name="lung">Tumors of the lung: epidemiology. WHO/IARC. 2006 https://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/bb10-chap1.pdf Accessed on February 21, 2016</ref> | ||
* There is a higher prevalence of lung adenocarcinoma among Asian female patients with EGFR mutation (51.4%) | ** There is a higher prevalence of lung adenocarcinoma among Asian female patients with EGFR mutation (51.4%). | ||
* Shown below is an image that demonstrates the mortality rate of non small cell lung cancer among different ethnic groups in the United States. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute<ref name="pmid19934774">{{cite journal |vauthors=Subramanian J, Morgensztern D, Goodgame B, Baggstrom MQ, Gao F, Piccirillo J, Govindan R |title=Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis |journal=J Thorac Oncol |volume=5 |issue=1 |pages=23–8 |year=2010 |pmid=19934774 |doi=10.1097/JTO.0b013e3181c41e8d |url=}}</ref> | * Shown below is an image that demonstrates the mortality rate of non-small cell lung cancer among different ethnic groups in the United States. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.<ref name="pmid19934774">{{cite journal |vauthors=Subramanian J, Morgensztern D, Goodgame B, Baggstrom MQ, Gao F, Piccirillo J, Govindan R |title=Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis |journal=J Thorac Oncol |volume=5 |issue=1 |pages=23–8 |year=2010 |pmid=19934774 |doi=10.1097/JTO.0b013e3181c41e8d |url=}}</ref> | ||
==References== | ==References== | ||
Latest revision as of 20:09, 27 March 2018
|
Non Small Cell Lung Cancer Microchapters |
|
Differentiating Non Small Cell Lung Cancer from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Non small cell lung cancer epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Non small cell lung cancer epidemiology and demographics |
|
FDA on Non small cell lung cancer epidemiology and demographics |
|
CDC on Non small cell lung cancer epidemiology and demographics |
|
Non small cell lung cancer epidemiology and demographics in the news |
|
Blogs on Non small cell lung cancer epidemiology and demographics |
|
Directions to Hospitals Treating Non small cell carcinoma of the lung |
|
Risk calculators and risk factors for Non small cell lung cancer epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2] Maria Fernanda Villarreal, M.D. [3]
Overview
Non-small cell lung cancer is the most common cancer worldwide and the leading cause of cancer-related mortality in the United States. Non-small cell lung cancer accounted for 1.8 million new cases and 1.6 million deaths of lung cancer in 2012. In the United States, the age-adjusted prevalence of non-small cell lung cancer is 47.2 per 100,000 individuals. The median age at diagnosis of non-small cell lung cancer is 70 years. Non-small cell lung cancer is most frequently diagnosed among people between 65 to 74 years old. Males are more commonly affected by non-small cell lung cancer than females. The male to female ratio is approximately 1.8 to 1. The rate of new cases in 2011 showed that males develop lung cancer more often than females (64.8 and 48.6 per 100,000 individuals). There is a racial preponderance to the development of non-small cell lung cancer, where African American individuals are at a significantly increased risk compared to Caucasian race.
Epidemiology and Demographics
Prevalence
- In the United States, the age-adjusted prevalence of non-small cell lung cancer is 47.2 per 100,000 indivudals.[1]
- About 85%–90% of all lung cancers are non-small cell lung cancer.[2]
- The most common type of lung cancer is non-small cell lung cancer.[3][4]
- Non-small cell lung cancer is the most common cancer worldwide, accounting for 1.8 million new cases and 1.6 million deaths in 2012.
- Adenocarcinoma of the lung is the most common non-small cell lung cancer subtype in the United States.
Incidence
- The age-adjusted incidence of non-small cell lung cancer in 2012 was estimated to be 58.7 per 100,000 individuals in the United States.[1]
- The incidence rate of lung adenocarcinoma is 22.1 per 100,000 individuals a year.
- The incidence rate of lung squamous-cell carcinoma is 14.4 per 100,000 individuals a year.
Age
- The incidence of non small cell lung cancer increases with age; the median age at diagnosis is 70 years.[5]
- Non small cell lung cancer is most frequently diagnosed among people among 65 to 74 years old.
- Shown below is an image that demonstrates the age-adjusted incidence of non-small cell lung cancer in the United States. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.
Gender
- Males are more commonly affected with non-small cell lung cancer than females. The male to female ratio is approximately 1.8 to 1.[5]
- The rate of new cases in 2011 showed that males develop lung cancer more often than females (64.8 and 48.6 per 100,000 individuals).
- Shown below is an image that demonstrates the relative proportions of common types of non-small cell lung cancer in the United States, by histology and gender. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.
Race
- There is a racial preponderance to the development of non small cell lung cancer, where African American individuals are at a significantly increased risk compared to Caucasian race.[4]
- There is a higher prevalence of lung adenocarcinoma among Asian female patients with EGFR mutation (51.4%).
- Shown below is an image that demonstrates the mortality rate of non-small cell lung cancer among different ethnic groups in the United States. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.[5]
References
- ↑ 1.0 1.1 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/statfacts/html/lungb.html, based on November 2013 SEER data submission, posted to the SEER web site. February 2016.
- ↑ Non small cell lung cancer. Canadian cancer society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/lung/lung-cancer/non-small-cell-lung-cancer/?region=ab
- ↑ Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA (2008). "Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship". Mayo Clin. Proc. 83 (5): 584–94. doi:10.4065/83.5.584. PMC 2718421. PMID 18452692.
- ↑ 4.0 4.1 Tumors of the lung: epidemiology. WHO/IARC. 2006 https://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/bb10-chap1.pdf Accessed on February 21, 2016
- ↑ 5.0 5.1 5.2 Subramanian J, Morgensztern D, Goodgame B, Baggstrom MQ, Gao F, Piccirillo J, Govindan R (2010). "Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis". J Thorac Oncol. 5 (1): 23–8. doi:10.1097/JTO.0b013e3181c41e8d. PMID 19934774.